Louis successfully defended his PhD research entitled “Inhibiting PI3K/Akt to Enhance Brain Uptake of Anticancer Agents in Glioblastoma.” Louis joined the BHL in 2019 as an MD/PhD student studying the overexpression of drug-efflux pumps in glioblastoma and the development of a novel therapeutic strategy to increase brain uptake of anticancer drugs. Louis will now continue finishing his MD in the College of Medicine at the University of Kentucky. Congratulations, Louis!

Valerie featured in UKNow
UKNow featured Valerie and her participation in the Sanders-Brown Center on Aging NIH-funded Kentucky Alzheimer’s Disease Postbaccalaureate Research Education Program (KYAD-PREP). The program provided Valerie with mentored research experience in Alzheimer’s disease and related disorders before beginning her PhD training at UK. Read the full story in UKNow.

